Cargando…
May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
COVID-19 pandemic is a major challenge for global and national healthcare providers. Number of new cases is continuously increasing with an emerging trend showing worse prognosis in males in comparison to females. Based on this observation, our proposed hypothesis is that 5-alpha-reductase inhibitor...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175887/ https://www.ncbi.nlm.nih.gov/pubmed/32344304 http://dx.doi.org/10.1016/j.mehy.2020.109751 |